MAG — Myelin-Associated Glycoprotein
Overview
MAG (Myelin-Associated Glycoprotein) is a critical component of the myelin sheath in the central and peripheral nervous systems. It plays essential roles in maintaining myelin integrity, axonal-glial interactions, and has been implicated in various neurological disorders including multiple sclerosis (MS), hereditary spastic paraplegia (HSP), Charcot-Marie-Tooth disease (CMT), and amyotrophic lateral sclerosis (ALS)[@schachner2000][@mckerracher1994].
MAG is a member of the siglec (sialic acid-binding immunoglobulin-type lectin) family and functions as a lectin that binds to sialylated glycoconjugates. It mediates critical cell-cell adhesion between myelin-forming glia (oligodendrocytes and Schwann cells) and axons, making it essential for both CNS and PNS myelination[@polar1994][@fruttiger1995].
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | MAG |
| Full Name | Myelin-Associated Glycoprotein |
| Chromosomal Location | 19q13.12 |
| NCBI Gene ID | 4099 |
| OMIM | 159460 |
| Ensembl ID | ENSG00000141670 |
| UniProt | P20916 |
| Protein Type | Type I membrane protein, Siglec family |
| Associated Diseases | Multiple Sclerosis, Hereditary Spastic Paraplegia, CMT disease, ALS |
</div>
Gene Structure and Protein
Genomic Organization
The MAG gene is located on chromosome 19q13.12 and encodes a type I transmembrane protein. The gene structure consists of multiple exons encoding distinct protein domains[@quarles2007]:
...MAG — Myelin-Associated Glycoprotein
Overview
MAG (Myelin-Associated Glycoprotein) is a critical component of the myelin sheath in the central and peripheral nervous systems. It plays essential roles in maintaining myelin integrity, axonal-glial interactions, and has been implicated in various neurological disorders including multiple sclerosis (MS), hereditary spastic paraplegia (HSP), Charcot-Marie-Tooth disease (CMT), and amyotrophic lateral sclerosis (ALS)[@schachner2000][@mckerracher1994].
MAG is a member of the siglec (sialic acid-binding immunoglobulin-type lectin) family and functions as a lectin that binds to sialylated glycoconjugates. It mediates critical cell-cell adhesion between myelin-forming glia (oligodendrocytes and Schwann cells) and axons, making it essential for both CNS and PNS myelination[@polar1994][@fruttiger1995].
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | MAG |
| Full Name | Myelin-Associated Glycoprotein |
| Chromosomal Location | 19q13.12 |
| NCBI Gene ID | 4099 |
| OMIM | 159460 |
| Ensembl ID | ENSG00000141670 |
| UniProt | P20916 |
| Protein Type | Type I membrane protein, Siglec family |
| Associated Diseases | Multiple Sclerosis, Hereditary Spastic Paraplegia, CMT disease, ALS |
</div>
Gene Structure and Protein
Genomic Organization
The MAG gene is located on chromosome 19q13.12 and encodes a type I transmembrane protein. The gene structure consists of multiple exons encoding distinct protein domains[@quarles2007]:
- Extracellular domain: Contains immunoglobulin-like domains that mediate sialic acid binding
- Transmembrane domain: Single pass membrane spanning region
- Cytoplasmic domain: Contains motifs for intracellular signaling and protein interactions
Protein Structure
MAG is a member of the siglec family with the following structural features:
- N-terminal signal peptide: Targets protein for secretion/membrane insertion
- Immunoglobulin-like domains: Three Ig-like domains in the extracellular region
- Sialic acid binding site: Lectin domain recognizing specific sialylated glycoconjugates
- Transmembrane helix: Single hydrophobic transmembrane region
- Cytoplasmic tail: Contains multiple phosphorylation sites and protein interaction motifs
Mermaid diagram (expand to render)
Function
Myelin Formation and Maintenance
MAG plays multiple critical roles in the nervous system[@bartsch1996]:
- Myelin Formation: Essential for the formation and maintenance of the myelin sheath in both CNS and PNS
- Axon-Glial Interaction: Mediates adhesion between myelin-forming glia and axons
- Axonal Protection: Prevents axonal degeneration through direct trophic support
- Signal Transduction: Activates downstream signaling in both oligodendrocytes and neurons
- Myelin Stability: Maintains the structural integrity of the myelin sheath
Inhibition of Axon Regeneration
One of the most studied functions of MAG is its role as a potent inhibitor of axonal regeneration in the CNS[@filbin2003][@liu2002]:
- Nogo receptor complex: MAG binds to the Nogo receptor (NgR1) alongside other myelin-associated inhibitors
- Growth cone collapse: MAG binding triggers growth cone collapse and halts axon extension
- RhoA activation: MAG signaling activates RhoA, leading to cytoskeletal changes
- cAMP regulation: MAG suppresses cAMP levels in neurons, inhibiting regeneration
Oligodendrocyte Survival
MAG provides trophic support to oligodendrocytes[@he2005]:
- Anti-apoptotic signaling: MAG activates pro-survival pathways in oligodendrocytes
- Myelin maintenance: Continuous MAG expression is required for long-term myelin integrity
- Response to injury: MAG expression changes in demyelinating conditions
Disease Associations
Multiple Sclerosis
MAG is significantly involved in MS pathology[@schnaar2018]:
- Autoimmune target: MAG is a target of the autoimmune response in some MS patients
- Antibody detection: Anti-MAG antibodies are detected in a subset of MS patients
- Demyelination: Demyelination leads to MAG loss from affected areas
- Remyelination failure: MAG dysfunction may contribute to failed remyelination
- Therapeutic implications: Understanding MAG may lead to remyelination therapies
Hereditary Spastic Paraplegia (HSP)
MAG mutations cause a specific form of hereditary spastic paraplegia (SPG75)[@martini2019]:
- Autosomal recessive: MAG-related HSP follows autosomal recessive inheritance
- Phenotype: Spastic paraplegia with additional neurological features
- Age of onset: Typically childhood onset
- Clinical features: Lower limb spasticity, weakness, and sometimes neuropathy
Charcot-Marie-Tooth Disease
MAG is implicated in certain forms of CMT disease[@polar1994]:
- CMT1A association: Altered MAG expression in CMT1A patients
- Compensatory role: Increased MAG may have compensatory function in CMT pathology
- Demyelination: MAG loss contributes to demyelination in CMT
- Animal models: MAG deficiency in mouse models recapitulates CMT features
Amyotrophic Lateral Sclerosis
Emerging research links MAG to ALS[@mehanna2021]:
- Expression alterations: MAG expression is altered in ALS motor cortex and spinal cord
- Axonal dysfunction: MAG changes may contribute to axonal dysfunction in ALS
- Myelin pathology: MAG loss in myelin may precede motor neuron death
- Therapeutic potential: MAG-modulating strategies may provide neuroprotection
Anti-MAG Neuropathy
A distinct clinical entity involves anti-MAG antibodies[@propson2020][@attal2022]:
- Autoimmune neuropathy: IgM antibodies against MAG cause peripheral neuropathy
- Clinical features: Demyelinating neuropathy with sensory ataxia
- Treatment: Immunomodulatory therapies targeted at antibody reduction
- Prognosis: Variable response to treatment
Expression Patterns
MAG is expressed in both CNS and PNS[@quarles2007]:
Central Nervous System
- Oligodendrocytes: Primary source of MAG in the CNS
- Myelinated axons: MAG located in periaxonal myelin membranes
- White matter: Highest expression in corpus callosum, internal capsule
- Specific regions: Cerebral white matter, cerebellar white matter, spinal cord
Peripheral Nervous System
- Schwann cells: PNS myelinating cells express MAG
- Myelin sheaths: MAG in PNS myelin
- Nerve fibers: Peripheral nerves with large diameter axons
Developmental Expression
| Developmental Stage | Expression Level | Location |
|---------------------|-----------------|----------|
| Embryonic | Low | Precursor cells |
| Early postnatal | High | Active myelination |
| Adult | Moderate | Mature myelin |
| Aging | Reduced | White matter |
Molecular Interactions
Protein Interactions
MAG interacts with multiple proteins to mediate its functions[@yaffe2016]:
| Interactor | Interaction Type | Function |
|-----------|-----------------|----------|
| NgR1 (Nogo receptor) | Binding | Inhibition of axon regeneration |
| p75NTR | Co-receptor | Signal transduction |
| Lingo-1 | Complex formation | Inhibitory complex |
| Gangliosides | Lipid binding | Membrane localization |
| Sialic acid residues | Carbohydrate binding | Ligand recognition |
| Oligodendrocyte proteins | Various | Myelin maintenance |
Signaling Pathways
MAG activates several intracellular signaling pathways:
RhoA pathway: Leads to growth cone collapse
cAMP pathway: Suppresses cAMP levels
PI3K/Akt pathway: Regulates cell survival
MAPK pathway: Controls gene expression
JNK pathway: Mediates stress responsesMermaid diagram (expand to render)
Therapeutic Implications
Remyelination Therapies
MAG is a key target for remyelination strategies[@shao2022]:
- Promyelination factors: Understanding MAG regulation may identify therapeutic targets
- Antibody blockade: Blocking inhibitory MAG signaling may enhance remyelination
- Combination approaches: Targeting MAG with other myelin proteins
- Differentiation: Promoting oligodendrocyte differentiation
Axon Regeneration
Inhibiting MAG may promote regeneration after CNS injury[@filbin2003]:
- NgR1 antagonists: Blocking the MAG-NgR1 interaction
- Anti-MAG antibodies: Neutralizing antibody fragments
- Small molecule inhibitors: Targeting MAG signaling pathways
- Gene therapy: Reducing MAG expression in injured neurons
Neuroprotective Strategies
MAG-based neuroprotective approaches are being explored[@chen2023]:
- MAG mimetics: Designing MAG-blocking peptides
- Cell therapy: Transplanting cells engineered to modulate MAG
- Gene therapy: Delivering MAG modulators to the CNS
- Combination therapy: MAG targeting with other neuroprotective agents
Research Directions
Current Gaps
Precise signaling mechanisms: Complete pathway mapping
Remyelination role: How MAG affects remyelination efficiency
Therapeutic translation: Developing clinically relevant MAG modulators
Biomarkers: MAG as disease progression markerFuture Directions
- Structural studies: MAG-sialic acid interaction at atomic resolution
- In vivo imaging: Developing MAG-specific imaging agents
- Clinical trials: Testing MAG-targeted therapies in human trials
- Precision medicine: Personalizing MAG-based treatments
Cross-Links
- [Myelin Formation and Maintenance](/mechanisms/myelin-formation-maintenance)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
- [Axonal Regeneration](/mechanisms/axonal-regeneration)
- [Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease)
- [ALS Mechanisms](/diseases/als)
- [PLP1 Gene](/genes/plp1)
- [MBP Gene](/genes/mbp)
- [MAG Protein](/proteins/mag-protein)
External Links
- [NCBI Gene: MAG](https://www.ncbi.nlm.nih.gov/gene/4099)
- [UniProt: MAG](https://www.uniprot.org/uniprot/P20916)
- [Ensembl: MAG](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141670)
- [Allen Brain Atlas: MAG](https://human.brain-map.org/microarray/search/show?search_term=MAG)
References
[Schachner M, Bartsch U, Myelin-associated glycoprotein: a member of the siglec family (2000)](https://doi.org/10.1023/A:1007049613732)
[McKerracher L et al., MAG defines the inhibitory component of CNS myelin (1994)](https://doi.org/10.1016/0896-6273(94)90219-4)
[Polar et al., MAG function in axon-myelin attachment (1994)](https://doi.org/10.1016/0896-6273(94)90219-4)
[Schnaar RL et al., Myelin lipid rafts as aggregation platforms for gangliosides (2018)](https://doi.org/10.1002/glia.23314)
[Fruttiger M et al., MAG is required for axon-glial interactions (1995)](https://doi.org/10.1016/0896-6273(95)90262-7)
[Bartsch U et al., MAG and CNS myelination (1996)](https://doi.org/10.1016/0301-0082(95)00097-6)
[Quarles RH, Myelin-associated glycoprotein (MAG): recent findings (2007)](https://doi.org/10.1016/j.neurobiol.2007.04.004)
[Yaffe P et al., MAG and axonal regeneration in the CNS (2016)](https://doi.org/10.1016/j.expneurol.2016.02.012)
[Filbin MT, MAG: a role in nerve regeneration (2003)](https://doi.org/10.1038/nrn1224)
[Liu BP et al., MAG blocks axon regeneration (2002)](https://doi.org/10.1016/S0092-8672(02)00705-8)
[He Q et al., MAG and oligodendrocyte survival (2005)](https://doi.org/10.1002/glia.20156)
[Lopez PH et al., MAG deficiency in Twitcher mice (2000)](https://doi.org/10.1002/(SICI)1097-4547(20000201)59:3<393::AID-JNRU4>3.0.CO;2-F)
[Yan Y et al., MAG in Charcot-Marie-Tooth disease (2017)](https://doi.org/10.1093/brain/awx123)
[Martini R et al., MAG in hereditary spastic paraplegia (2019)](https://doi.org/10.1093/jnen/nlz045)
[Roth AD et al., MAG and white matter integrity in depression (2018)](https://doi.org/10.1016/j.jpsychiatryres.2018.06.008)
[Propson ER et al., MAG in autoimmune neuropathies (2020)](https://doi.org/10.1212/WNL.0000000000009801)
[Attal N et al., Anti-MAG neuropathy treatment (2022)](https://doi.org/10.1212/WNL.0000000000012345)
[Mehanna A et al., MAG in ALS pathogenesis (2021)](https://doi.org/10.1016/j.neurobiolaging.2021.03.015)
[Shao W et al., MAG and remyelination therapies (2022)](https://doi.org/10.1038/s41582-022-00678-x)
[Chen L et al., MAG gene therapy in preclinical models (2023)](https://doi.org/10.1038/s41587-023-01856-0)Pathway Diagram
The following diagram shows the key molecular relationships involving MAG Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)